Kalvista Pharmaceuticals Inc

NASDAQ KALV

Data sourced from

and

Download Data

Kalvista Pharmaceuticals Inc Gross Profit Per Share 1 year YoY Change (%) for the quarter ending January 31, 2024: 19.34%

Kalvista Pharmaceuticals Inc Gross Profit Per Share 1 year YoY Change (%) is 19.34% for the quarter ending January 31, 2024, a 117.85% change year over year. Gross Profit per Share represents the gross profit allocated to each outstanding share of common stock. It provides insight into the per-share value of gross profit and is commonly used in valuation analysis. A higher value suggests a potentially more favorable investment opportunity. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.

Kalvista Pharmaceuticals Inc Gross Profit Per Share for the quarter ending January 31, 2023 was -0.01.
Kalvista Pharmaceuticals Inc Gross Profit Per Share for the quarter ending January 31, 2020 was 0.09, a -60.84% change year over year.

NASDAQ: KALV

Kalvista Pharmaceuticals Inc

CEO	Mr. Thomas Andrew Crockett M.B.A.
IPO Date	April 9, 2015
Location	United States
Headquarters	55 Cambridge Parkway, Cambridge, MA, United States, 02142
Employees	118
Sector	Healthcare
Industry	Biotechnology

Description

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, engages in the discovery, development, and commercialization of small molecule protease inhibitors for diseases with unmet needs in the United States. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral plasma kallikrein inhibitors. Its products include sebetralstat, which is initiation of the Phase 3 KONFIDENT trial as a potential oral, on-demand therapy for HAE attacks; and Factor XIIa, an oral inhibitor program which is in preclinical stage targets an enzyme in HAE. The company is headquartered in Cambridge, Massachusetts.

Key trends